Skip to main content
Clinical Trials/NCT00065650
NCT00065650CompletedPhase 2

Pilot Study of Vedic Medicine for Type 2 Diabetes

National Center for Complementary and Integrative Health (NCCIH)1 site in 1 country60 target enrollmentStarted: July 1, 2003Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
60
Locations
1
Primary Endpoint
HbA1C

Study Overview

Brief Summary

The purpose of this study is to determine the feasibility and effectiveness of a multimodality Vedic Medicine treatment protocol for the management of newly diagnosed type 2 diabetes.

Detailed Description

Maharishi Vedic Medicine (MVM) represents a synthesis of Vedic sciences, including Ayur-Veda, into a single, comprehensive, natural approach to health care. The objectives of this phase II pilot trial are to determine the feasibility, acceptability, and safety of implementing a multi-modality MVM intervention for newly diagnosed type 2 diabetics, and to measure the impact of such a protocol on overall glycemic control.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
25 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Kaiser Permanente members
  • •Newly diagnosed type 2 Diabetes
  • •Baseline glycosylated hemoglobin level of 6.0-7.9.

Exclusion Criteria

  • •Pregnancy or nursing mother
  • •Currently taking warfarin
  • •Diagnosis of psychotic disorder or recent hospitalization for depression
  • •Unable to comply with or attend treatment sessions

Outcomes

Primary Outcomes

HbA1C

Time Frame: 3 months

Secondary Outcomes

  • Lipids(3 and 6 months)
  • Fasting Glucose(3 and 6 months)

Investigators

Study Sites (1)

Loading locations...

Similar Trials